DOLBY LABORATORIES INC-CL A (DLB) Fundamental Analysis & Valuation
NYSE:DLB • US25659T1079
Current stock price
58.03 USD
-0.7 (-1.19%)
At close:
58.03 USD
0 (0%)
After Hours:
This DLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DLB Profitability Analysis
1.1 Basic Checks
- In the past year DLB was profitable.
- DLB had a positive operating cash flow in the past year.
- DLB had positive earnings in each of the past 5 years.
- In the past 5 years DLB always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.53%, DLB belongs to the top of the industry, outperforming 81.30% of the companies in the same industry.
- The Return On Equity of DLB (9.27%) is better than 73.74% of its industry peers.
- The Return On Invested Capital of DLB (8.23%) is better than 80.58% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for DLB is below the industry average of 10.92%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 9.27% | ||
| ROIC | 8.23% |
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
1.3 Margins
- With an excellent Profit Margin value of 17.97%, DLB belongs to the best of the industry, outperforming 84.53% of the companies in the same industry.
- In the last couple of years the Profit Margin of DLB has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 19.98%, DLB belongs to the top of the industry, outperforming 87.41% of the companies in the same industry.
- In the last couple of years the Operating Margin of DLB has grown nicely.
- DLB has a Gross Margin of 87.86%. This is amongst the best in the industry. DLB outperforms 94.96% of its industry peers.
- In the last couple of years the Gross Margin of DLB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.98% | ||
| PM (TTM) | 17.97% | ||
| GM | 87.86% |
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
2. DLB Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DLB is destroying value.
- Compared to 1 year ago, DLB has about the same amount of shares outstanding.
- Compared to 5 years ago, DLB has less shares outstanding
- There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 7.76 indicates that DLB is not in any danger for bankruptcy at the moment.
- DLB has a better Altman-Z score (7.76) than 88.49% of its industry peers.
- DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.76 |
ROIC/WACC0.75
WACC11.02%
2.3 Liquidity
- DLB has a Current Ratio of 3.17. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 3.17, DLB is doing good in the industry, outperforming 75.18% of the companies in the same industry.
- DLB has a Quick Ratio of 3.10. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.10, DLB is in the better half of the industry, outperforming 74.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.17 | ||
| Quick Ratio | 3.1 |
3. DLB Growth Analysis
3.1 Past
- DLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.11%.
- DLB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.55% yearly.
- Looking at the last year, DLB shows a small growth in Revenue. The Revenue has grown by 1.80% in the last year.
- Measured over the past years, DLB shows a small growth in Revenue. The Revenue has been growing by 3.03% on average per year.
EPS 1Y (TTM)6.11%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%-7.02%
Revenue 1Y (TTM)1.8%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%-2.88%
3.2 Future
- The Earnings Per Share is expected to grow by 6.48% on average over the next years.
- The Revenue is expected to grow by 4.93% on average over the next years.
EPS Next Y3.14%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue Next Year5.37%
Revenue Next 2Y4.6%
Revenue Next 3Y4.93%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. DLB Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 13.92, the valuation of DLB can be described as correct.
- Based on the Price/Earnings ratio, DLB is valued cheaply inside the industry as 80.94% of the companies are valued more expensively.
- DLB is valuated rather cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
- DLB is valuated correctly with a Price/Forward Earnings ratio of 12.40.
- Based on the Price/Forward Earnings ratio, DLB is valued a bit cheaper than the industry average as 79.50% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, DLB is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.92 | ||
| Fwd PE | 12.4 |
4.2 Price Multiples
- DLB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DLB is cheaper than 80.22% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, DLB is valued cheaply inside the industry as 80.58% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.6 | ||
| EV/EBITDA | 13.72 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of DLB may justify a higher PE ratio.
PEG (NY)4.43
PEG (5Y)1.63
EPS Next 2Y4.93%
EPS Next 3Y6.48%
5. DLB Dividend Analysis
5.1 Amount
- DLB has a Yearly Dividend Yield of 2.45%.
- DLB's Dividend Yield is rather good when compared to the industry average which is at 0.64. DLB pays more dividend than 94.60% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, DLB pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
5.2 History
- The dividend of DLB is nicely growing with an annual growth rate of 8.45%!
- DLB has paid a dividend for at least 10 years, which is a reliable track record.
- DLB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.45%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
- DLB pays out 53.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of DLB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP53.8%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
DLB Fundamentals: All Metrics, Ratios and Statistics
58.03
-0.7 (-1.19%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-29 2026-01-29/amc
Earnings (Next)04-29 2026-04-29
Inst Owners99.45%
Inst Owner Change1.96%
Ins Owners1.28%
Ins Owner Change7.28%
Market Cap5.54B
Revenue(TTM)1.34B
Net Income(TTM)240.52M
Analysts80
Price Target89.58 (54.37%)
Short Float %5.88%
Short Ratio4.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
Yearly Dividend1.33
Dividend Growth(5Y)8.45%
DP53.8%
Div Incr Years10
Div Non Decr Years10
Ex-Date02-10 2026-02-10 (0.36)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.87%
Min EPS beat(2)19.71%
Max EPS beat(2)40.03%
EPS beat(4)4
Avg EPS beat(4)18.19%
Min EPS beat(4)4.74%
Max EPS beat(4)40.03%
EPS beat(8)8
Avg EPS beat(8)14.94%
EPS beat(12)11
Avg EPS beat(12)15.41%
EPS beat(16)14
Avg EPS beat(16)15.04%
Revenue beat(2)1
Avg Revenue beat(2)1.53%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)3.3%
Revenue beat(4)2
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)3.3%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)5
Avg Revenue beat(12)0.53%
Revenue beat(16)6
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)-2.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.97%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.92 | ||
| Fwd PE | 12.4 | ||
| P/S | 4.14 | ||
| P/FCF | 14.6 | ||
| P/OCF | 13.19 | ||
| P/B | 2.14 | ||
| P/tB | 3.26 | ||
| EV/EBITDA | 13.72 |
EPS(TTM)4.17
EY7.19%
EPS(NY)4.68
Fwd EY8.06%
FCF(TTM)3.97
FCFY6.85%
OCF(TTM)4.4
OCFY7.58%
SpS14.01
BVpS27.15
TBVpS17.79
PEG (NY)4.43
PEG (5Y)1.63
Graham Number50.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 9.27% | ||
| ROCE | 9.73% | ||
| ROIC | 8.23% | ||
| ROICexc | 10.75% | ||
| ROICexgc | 18.7% | ||
| OM | 19.98% | ||
| PM (TTM) | 17.97% | ||
| GM | 87.86% | ||
| FCFM | 28.36% |
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
ROICexc(3y)11.58%
ROICexc(5y)13.02%
ROICexgc(3y)19.56%
ROICexgc(5y)20.42%
ROCE(3y)10.05%
ROCE(5y)10.27%
ROICexgc growth 3Y7.72%
ROICexgc growth 5Y2.66%
ROICexc growth 3Y-0.34%
ROICexc growth 5Y-1.41%
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.24% | ||
| Cap/Sales | 3.03% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 117.67% | ||
| Profit Quality | 157.85% | ||
| Current Ratio | 3.17 | ||
| Quick Ratio | 3.1 | ||
| Altman-Z | 7.76 |
F-Score7
WACC11.02%
ROIC/WACC0.75
Cap/Depr(3y)41.38%
Cap/Depr(5y)49.64%
Cap/Sales(3y)2.6%
Cap/Sales(5y)3.36%
Profit Quality(3y)150.02%
Profit Quality(5y)143.52%
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%-7.02%
EPS Next Y3.14%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue 1Y (TTM)1.8%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%-2.88%
Revenue Next Year5.37%
Revenue Next 2Y4.6%
Revenue Next 3Y4.93%
Revenue Next 5YN/A
EBIT growth 1Y-3.6%
EBIT growth 3Y8.83%
EBIT growth 5Y4.89%
EBIT Next Year23.78%
EBIT Next 3Y11.88%
EBIT Next 5YN/A
FCF growth 1Y30.96%
FCF growth 3Y18.42%
FCF growth 5Y9.38%
OCF growth 1Y31.68%
OCF growth 3Y14.01%
OCF growth 5Y6.55%
DOLBY LABORATORIES INC-CL A / DLB Fundamental Analysis FAQ
What is the fundamental rating for DLB stock?
ChartMill assigns a fundamental rating of 7 / 10 to DLB.
What is the valuation status for DLB stock?
ChartMill assigns a valuation rating of 6 / 10 to DOLBY LABORATORIES INC-CL A (DLB). This can be considered as Fairly Valued.
What is the profitability of DLB stock?
DOLBY LABORATORIES INC-CL A (DLB) has a profitability rating of 8 / 10.
What is the expected EPS growth for DOLBY LABORATORIES INC-CL A (DLB) stock?
The Earnings per Share (EPS) of DOLBY LABORATORIES INC-CL A (DLB) is expected to grow by 3.14% in the next year.
Can you provide the dividend sustainability for DLB stock?
The dividend rating of DOLBY LABORATORIES INC-CL A (DLB) is 7 / 10 and the dividend payout ratio is 53.8%.